insights_auto
Kwa nini AGIO imepungua kwa 3.10%?
Fahamu zaidichevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ 28.76
arrow_downward
-3.10%(-0.92) Siku 1
US$ 28.76
0.00% (0.00)
bedtimeBaada ya saa
Imefungwa: 19 Nov, 16:00:01 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya AGIO...
Fungua
US$ 29.93
Juu
US$ 30.35
Chini
US$ 28.71
Mtaji wa soko
1.72B
Wastani wa kiasi cha mauzo
1.18M
Kiasi cha mauzo ya hisa
elfu 469.84
Juu kwa wiki 52
US$ 44.07
Chini kwa wiki 52
US$ 23.02
EPS
-US$ 6.32
Beta
0.66
Hisa za wawekezaji
59.81M
Idadi ya wafanyakazi
540
Fungua
US$ 29.93
Juu
US$ 30.35
Chini
US$ 28.71
Mtaji wa soko
1.72B
Wastani wa kiasi cha mauzo
1.18M
Kiasi cha mauzo ya hisa
elfu 469.84
Juu kwa wiki 52
US$ 44.07
Chini kwa wiki 52
US$ 23.02
EPS
-US$ 6.32
Beta
0.66
Hisa za wawekezaji
59.81M
Idadi ya wafanyakazi
540
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Traders Union
·
dakika 12 zilizopita
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
FXStreet
·
dakika 46 zilizopita
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Investing.com
·
dakika 38 zilizopita
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.19%
ChartMill
·
saa 2 zilizopita
S&P 500 Top Movers: Gainers and Losers Today
Wasifu
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Kuhusu Agios Pharmaceuticals Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi540
Lilianzishwa2008
Makao makuu-
SektaHealth Care
Sekta-
Tovutiagios.com